Nexell Therapeutics Inc.

The Irvine supplier of therapeutic and diagnostic products reported a third-quarter net loss of $13 million, or 18 cents a share, compared with a net loss of $11.6 million, or 17 cents a share, for the same period of 1998. Revenue declined 27% to $2.2 million.